Obesity Trial, Recruiting NCT06945016 Sponsor: Wageningen University and Research Condition: Obesity
Back to Obesity

Obesity Trial, Recruiting

NCT06945016
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who were female at birth
  • People aged between 18 and 55 years old
  • People living with obesity, meaning a Body Mass Index (BMI) of 30 or higher
  • People who have been approved for obesity treatment at one of the participating hospitals
  • People who are having a specific type of weight-loss surgery for the first time (one of three types: RYGB, OAGB, or sleeve gastrectomy)
  • People receiving any type of obesity medication under a doctor's supervision, with a BMI of 30 or higher
  • For those having certain scans (MRI, bone density scan, or ultrasound): people who are willing to be told if something unexpected is found and agree to have that information shared with their regular doctor

Additional criteria for the pregnancy group (birth cohort):

  • People who are currently pregnant
  • People aged between 18 and 45 years old
  • People who have previously had weight-loss surgery (RYGB, OAGB, or sleeve gastrectomy) or have been on obesity medication under medical supervision for at least 4 months

Who may not be able to join:

  • People who were male at birth
  • People under 18 or over 55 years old
  • People with a BMI below 30
  • People who are not able to read or write in Dutch
  • People having a repeat or revision weight-loss surgery (unless their only previous procedure was a gastric band)
  • People who have malnutrition caused by another ongoing condition, such as cancer or substance use
  • People whose mental or physical condition would make it impossible to complete questionnaires accurately (confirm with trial site)
  • For the bone density scan: people who are taller than 196 cm or weigh more than 160 kg
  • For the MRI scan: people with certain medical devices or implants (such as a pacemaker or defibrillator), metal fragments in or near the eyes, certain metallic implants, or claustrophobia

Additional exclusions for the pregnancy group (birth cohort):

  • People under 18 or over 45 years old
  • People who are more than 25 weeks pregnant
  • People carrying more than one baby (e.g., twins)
  • People who have had their weight-loss surgery reversed

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Wageningen University and Research
Registry
ClinicalTrials.gov
Start date
28 January 2025
Est. completion
28 January 2040

Where this trial is recruiting

🇳🇱 Netherlands

Primary endpoints

Body composition analysis; Handgrip strength; Timed Chair-stand-test/Five Times Sit to Stand test; Bone mineral density; Lean mass; Peak torque of knee extensors and flexors; Total work of knee extensors and flexors; Bone formation; Bone resorption; Proton density fraction in the bone marrow; Proton density fraction in the muscles of the thigh and back; Habitual dietary intake; Actual dietary intake; Nutrient status; Neonatal birth weight; Calcaneal Speed of Sound; Calcaneal Broadband Ultrasound Attenuation; Diet quality; Neonatal nutrient status; Fetal growth: biparietal diameter; Fetal growt...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov